Exact Mass: 642.3768

PA(14:0/18:3(6Z,9Z,12Z))

C35H63O8P (642.426)

PA(14:0/18:3(6Z,9Z,12Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(14:0/18:3(6Z,9Z,12Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of gamma-linolenic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(14:0/18:3(9Z,12Z,15Z))

C35H63O8P (642.426)

PA(14:0/18:3(9Z,12Z,15Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(14:0/18:3(9Z,12Z,15Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of alpha-linolenic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(14:1(9Z)/18:2(9Z,12Z))

C35H63O8P (642.426)

PA(14:1(9Z)/18:2(9Z,12Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(14:1(9Z)/18:2(9Z,12Z)), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of linoleic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(18:2(9Z,12Z)/14:1(9Z))

C35H63O8P (642.426)

PA(18:2(9Z,12Z)/14:1(9Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:2(9Z,12Z)/14:1(9Z)), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(18:3(6Z,9Z,12Z)/14:0)

C35H63O8P (642.426)

PA(18:3(6Z,9Z,12Z)/14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:3(6Z,9Z,12Z)/14:0), in particular, consists of one chain of gamma-linolenic acid at the C-1 position and one chain of myristic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(18:3(9Z,12Z,15Z)/14:0)

C35H63O8P (642.426)

PA(18:3(9Z,12Z,15Z)/14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:3(9Z,12Z,15Z)/14:0), in particular, consists of one chain of alpha-linolenic acid at the C-1 position and one chain of myristic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(10:0/PGJ2)

C33H55O10P (642.3533)

PA(10:0/PGJ2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/PGJ2), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of Prostaglandin J2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGJ2/10:0)

C33H55O10P (642.3533)

PA(PGJ2/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGJ2/10:0), in particular, consists of one chain of one Prostaglandin J2 at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Trifoliolasine A

C35H50N2O9 (642.3516)

Wikstroelide A

C36H50O10 (642.3404)

(+)-Tenuicausine

C41H46N4O3 (642.357)

Tsugarioside C

C38H58O8 (642.4131)

A triterpenoid saponin that is (23Z)-24-methyllanosta-8,23,25-trien-21-oic acid substituted by an acetyloxy group at position 3 and a beta-D-xylopyranosyl residue at position 21 via a glycosidic linkage. It has been isolated from the fruit bodied of Ganoderma tsugae and exhibits cytotoxic activity against several different cancer cell lines.

Irganox-1035

C38H58O6S (642.3954)

PM-2004-70-452-4

C40H50O7 (642.3556)

20-hydroxy-beta-ecdysone-3-O-beta-D-glucopyranoside|20-hydroxyecdysone 3-beta-D-glucopyranoside|20-hydroxyecdysone 3-O-beta-D-glucoside|20-Hydroxyecdysone-3-beta-D-glucopyranoside|Ecdysterone-3-O-??-D-glucopyranoside

C33H54O12 (642.3615)

16beta:23-epoxy-12beta-acetoxy-22,23-didehydro-24-one-25-hydro-9,19-cyclolanostane-7-ene-3-O-beta-D-xylopyranoside|asiaticoside B

C37H54O9 (642.3768)

17-[2,3-dihydroxy-6-methyl-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one

C33H54O12 (642.3615)

Ecdysterone-22-O-??-D-glucopyranoside

C33H54O12 (642.3615)

(24S,25R)-5alpha-Spirostan-2alpha,3beta,5alpha,6beta,24-pentaol 24-O-beta-D-glucopyranoside

C33H54O12 (642.3615)

onchidione

C37H54O9 (642.3768)

cyclo(Pro-Gly-Leu-Val-Ile-Tyr)|cyclo(Pro-Gly-Leu-Val-Ile-Tyr-)|glabrin A

C33H50N6O7 (642.3741)

onchitriol I B|Onchitriol IB

C37H54O9 (642.3768)

(3beta,20S)-pregn-5-ene-3,20-diol 20-[O-beta-glucopyranosyl-(1->6)-O-beta-glucopyranoside]

C33H54O12 (642.3615)

pentologenin 5-O-beta-D-glucopyranoside

C33H54O12 (642.3615)

pterosterone 24-O-beta-D-glucopyranoside

C33H54O12 (642.3615)

C36H50O10

C36H50O10 (642.3404)

wightianol-B tetraacetate

C38H58O8 (642.4131)

Bufolin-3-succinoylarginin-ester

C34H50N4O8 (642.3628)

(25R)-22alpha-methoxy-5beta-furostane-1beta,3beta,11alpha,26-tetraol 26-O-beta-D-glucopyranoside|caucasicoside G

C34H58O11 (642.3979)

(3beta,16delta)-olean-12-ene-3,16,23,28-tetrayl tetraacetate

C38H58O8 (642.4131)

munronoid K

C36H50O10 (642.3404)

(16S,19E)-2-(18E)-alstophyll-18-en-18-yl-(2alpha,7alpha)-2,7-dihydro-1,16-cyclo-coryn-19-en-17-oic acid methyl ester|macrocarpamine

C41H46N4O3 (642.357)

20??-Ecdysterone 2-O-??-D-glucopyranoside

C33H54O12 (642.3615)

(3beta,20S)-pregn-5-ene-3,20-diol 3-beta-glucopyranoside 20-beta-glucopyranoside|3-O-beta-D-glucopyranosyl-(3beta,20S)-pregn-5-ene-3,20-diol 20-O-beta-D-glucopyranoside|periseoside C

C33H54O12 (642.3615)

3-O-Demethylmonensin B

C34H58O11 (642.3979)

3beta,14alpha,15alpha,21beta,29-pentahydroxyserratane-24-oic acid 3beta-(4-hydroxybenzoate)

C37H54O9 (642.3768)

C34H58O11

C34H58O11 (642.3979)

onchitriol I C|Onchitriol IC

C37H54O9 (642.3768)

Tetra-Ac -(3beta,21beta,22alpha)-12-Oleanene-3,21,22,28-tetrol

C38H58O8 (642.4131)

Amphidinolide N

C33H54O12 (642.3615)

Gln Leu Asn Leu Lys

C29H54N8O8 (642.4064)

brassinolide-23-O-glucoside

C34H58O11 (642.3979)

NCGC00380118-01!

C36H50O10 (642.3404)

17-[2,3-dihydroxy-6-methyl-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one [IIN-based: Match]

C33H54O12 (642.3615)

Arg Arg Arg Arg

C24H50N16O5 (642.415)

PI(21:0/0:0)

C30H59O12P (642.3744)

PA(12:0/20:3(8Z,11Z,14Z))

C35H63O8P (642.426)

PA(14:0/18:3(6Z,9Z,12Z))

C35H63O8P (642.426)

PA(14:1(9Z)/18:2(9Z,12Z))

C35H63O8P (642.426)

PA(15:1(9Z)/17:2(9Z,12Z))

C35H63O8P (642.426)

PA(17:2(9Z,12Z)/15:1(9Z))

C35H63O8P (642.426)

PA(18:2(9Z,12Z)/14:1(9Z))

C35H63O8P (642.426)

PA(18:3(6Z,9Z,12Z)/14:0)

C35H63O8P (642.426)

PA(18:3(9Z,12Z,15Z)/14:0)

C35H63O8P (642.426)

PA(20:3(8Z,11Z,14Z)/12:0)

C35H63O8P (642.426)

PA(14:0/18:3(9Z,12Z,15Z))

C35H63O8P (642.426)

LPI 21:0

C30H59O12P (642.3744)

PA 32:3

C35H63O8P (642.426)

hellebrigenin-3-(14-hydroxymyristate)

C38H58O8 (642.4131)

calcium resinate

C40H58CaO4 (642.3961)

Calcium diabieta-7,13-dien-18-oate

C40H58CaO4 (642.3961)

Tasidotin hydrochloride

C32H59ClN6O5 (642.4235)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

bis[2-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]ethyl] 3,3-thiobispropionate

C38H58O6S (642.3954)

Silenoside A

C33H54O12 (642.3615)

N,N-[2,5-O-[Dibenzyl]-glucaryl]-DI-[isoleucyl-amido-methane]

C34H50N4O8 (642.3628)

17-[2,3-dihydroxy-6-methyl-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one

C33H54O12 (642.3615)

2,3,16-Triacetate-15-oxo-23,24-dihydroxycucurbitacin

C36H50O10 (642.3404)

PA(10:0/PGJ2)

C33H55O10P (642.3533)

PA(PGJ2/10:0)

C33H55O10P (642.3533)

2-[[(2R)-3-acetyloxy-2-[(5Z,7R,8E,10Z,13Z,15E,17S,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H53NO10P+ (642.3407)

2-[[(2R)-2-acetyloxy-3-[(5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H53NO10P+ (642.3407)

2-[[(2R)-3-acetyloxy-2-[(4Z,7Z,10R,11E,13Z,15E,17S,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H53NO10P+ (642.3407)

2-[[(2R)-2-acetyloxy-3-[(4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H53NO10P+ (642.3407)

casearupestrin D

C36H50O10 (642.3404)

12beta-Acetoxyhuratoxin

C36H50O10 (642.3404)

A natural product found in Pimelea elongata and Pimelea simplex.

brassinolide 23-O-glucoside

C34H58O11 (642.3979)

1,2-di-[(9Z)-hexadecenoyl]-sn-glycero-3-phosphate(2-)

C35H63O8P-2 (642.426)

dolichyl N-acetyl-alpha-D-glucosaminyl phosphate(1-)

C33H57NO9P- (642.3771)

NAGlySer 22:6/10:0

C37H58N2O7 (642.4244)

NAGlySer 16:3/16:3

C37H58N2O7 (642.4244)

NAGlySer 18:5/14:1

C37H58N2O7 (642.4244)

NAGlySer 16:4/16:2

C37H58N2O7 (642.4244)

[2-Hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] henicosanoate

C30H59O12P (642.3744)

Smgdg O-13:0_8:0

C30H58O12S (642.3649)

Smgdg O-15:0_6:0

C30H58O12S (642.3649)

Smgdg O-17:0_4:0

C30H58O12S (642.3649)

Smgdg O-14:0_7:0

C30H58O12S (642.3649)

Smgdg O-19:0_2:0

C30H58O12S (642.3649)

Smgdg O-18:0_3:0

C30H58O12S (642.3649)

Smgdg O-16:0_5:0

C30H58O12S (642.3649)

Smgdg O-8:0_13:0

C30H58O12S (642.3649)

Smgdg O-12:0_9:0

C30H58O12S (642.3649)

Smgdg O-9:0_12:0

C30H58O12S (642.3649)

Smgdg O-11:0_10:0

C30H58O12S (642.3649)

Smgdg O-10:0_11:0

C30H58O12S (642.3649)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] decanoate

C34H59O9P (642.3896)

[1-Decoxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] undecanoate

C30H59O12P (642.3744)

[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-undecoxypropan-2-yl] decanoate

C30H59O12P (642.3744)

[1-decoxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C34H59O9P (642.3896)

PMeOH 14:1_17:2

C35H63O8P (642.426)

PEtOH 14:1_16:2

C35H63O8P (642.426)

PEtOH 12:0_18:3

C35H63O8P (642.426)

PMeOH 13:1_18:2

C35H63O8P (642.426)

PMeOH 13:0_18:3

C35H63O8P (642.426)

PEtOH 13:1_17:2

C35H63O8P (642.426)

PMeOH 15:0_16:3

C35H63O8P (642.426)

PMeOH 15:1_16:2

C35H63O8P (642.426)

PEtOH 14:0_16:3

C35H63O8P (642.426)

[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C33H55O10P (642.3533)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C33H55O10P (642.3533)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C33H55O10P (642.3533)

[3-Acetyloxy-16-(furan-3-yl)-2,7,7,11,17-pentamethyl-10-(2-methylpropanoyloxy)-5-oxo-6,13-dioxapentacyclo[9.8.0.02,8.012,14.012,17]nonadecan-18-yl] 2-methylpropanoate

C36H50O10 (642.3404)

[1-Heptanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] tridecanoate

C29H55O13P (642.338)

[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-octanoyloxypropan-2-yl] dodecanoate

C29H55O13P (642.338)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C33H55O10P (642.3533)

[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] heptadecanoate

C29H55O13P (642.338)

[1-Butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] hexadecanoate

C29H55O13P (642.338)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C33H55O10P (642.3533)

[1-Hexanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] tetradecanoate

C29H55O13P (642.338)

[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] pentadecanoate

C29H55O13P (642.338)

[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-nonanoyloxypropan-2-yl] undecanoate

C29H55O13P (642.338)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C33H55O10P (642.3533)

[2-Decanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] decanoate

C29H55O13P (642.338)

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-phosphonooxypropyl] (Z)-hexadec-9-enoate

C35H63O8P (642.426)

(1-decanoyloxy-3-phosphonooxypropan-2-yl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C35H63O8P (642.426)

[1-phosphonooxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C35H63O8P (642.426)

[1-phosphonooxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C35H63O8P (642.426)

[1-[(Z)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C35H63O8P (642.426)

(1-phosphonooxy-3-tetradecanoyloxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C35H63O8P (642.426)

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-phosphonooxypropyl] hexadecanoate

C35H63O8P (642.426)

(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C35H63O8P (642.426)

[1-Acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] octadecanoate

C29H55O13P (642.338)

1-2-Di-decanoyl-sn-glycero-3-phosphoinositol

C29H55O13P (642.338)

[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] (9E,12E)-heptadeca-9,12-dienoate

C35H63O8P (642.426)

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (6E,9E,12E)-octadeca-6,9,12-trienoate

C35H63O8P (642.426)

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C33H55O10P (642.3533)

2-[[3-[(E)-dec-4-enoyl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H61NO8P+ (642.4135)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (8E,11E,14E)-icosa-8,11,14-trienoate

C35H63O8P (642.426)

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (6E,9E)-octadeca-6,9-dienoate

C35H63O8P (642.426)

[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-phosphonooxypropyl] (E)-hexadec-7-enoate

C35H63O8P (642.426)

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (9E,12E)-octadeca-9,12-dienoate

C35H63O8P (642.426)

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (6E,9E)-octadeca-6,9-dienoate

C35H63O8P (642.426)

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (2E,4E)-octadeca-2,4-dienoate

C35H63O8P (642.426)

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (9E,11E)-octadeca-9,11-dienoate

C35H63O8P (642.426)

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (9E,11E)-octadeca-9,11-dienoate

C35H63O8P (642.426)

[(2R)-1-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate

C35H63O8P (642.426)

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (9E,12E)-octadeca-9,12-dienoate

C35H63O8P (642.426)

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C35H63O8P (642.426)

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (6E,9E,12E)-octadeca-6,9,12-trienoate

C35H63O8P (642.426)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (5E,8E,11E)-icosa-5,8,11-trienoate

C35H63O8P (642.426)

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C35H63O8P (642.426)

[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropyl] hexadecanoate

C35H63O8P (642.426)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (5E,8E,11E)-icosa-5,8,11-trienoate

C35H63O8P (642.426)

2-[[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H61NO8P+ (642.4135)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (8E,11E,14E)-icosa-8,11,14-trienoate

C35H63O8P (642.426)

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (2E,4E)-octadeca-2,4-dienoate

C35H63O8P (642.426)

2-[[3-decanoyloxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H61NO8P+ (642.4135)

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(E)-undec-4-enoyl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C33H55O10P (642.3533)

2-[[3-acetyloxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H61NO8P+ (642.4135)

2-[[3-butanoyloxy-2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H61NO8P+ (642.4135)

2-[hydroxy-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H61NO8P+ (642.4135)

2-[[3-hexanoyloxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H61NO8P+ (642.4135)

2-[[3-decanoyloxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H61NO8P+ (642.4135)

1-heneicosanoyl-glycero-3-phospho-(1-myo-inositol)

C30H59O12P (642.3744)

1,2-di-[(9Z)-hexadecenoyl]-sn-glycero-3-phosphate(2-)

C35H63O8P (642.426)

A 1,2-diacyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1,2-di-[(9Z)-hexadecenoyl]-sn-glycero-3-phosphate

Casearupestrin D, (rel)-

C36H50O10 (642.3404)

A natural product found in Casearia rupestris.

brassinolide 23-O-alpha-D-glucoside

C34H58O11 (642.3979)

A brassinosteroid that is brassinolide carrying an alpha-D-glucosyl residue at position O-23.

SMGDG O-20:1;O

C29H54O13S (642.3285)

SMGDG O-21:0

C30H58O12S (642.3649)

SQDG 20:0;O

C29H54O13S (642.3285)

DGGA 24:3;O

C33H54O12 (642.3615)

DGGA 25:2

C34H58O11 (642.3979)

PA O-30:6;O3

C33H55O10P (642.3533)

PA O-31:5;O2

C34H59O9P (642.3896)

PA O-32:4;O

C35H63O8P (642.426)

PA P-18:0/13:4;O2

C34H59O9P (642.3896)

PA P-18:1/12:4;O3

C33H55O10P (642.3533)

PA P-18:1/13:3;O2

C34H59O9P (642.3896)

PA P-20:0/12:3;O

C35H63O8P (642.426)

PA 18:1/13:3;O

C34H59O9P (642.3896)

PA 18:2/12:3;O2

C33H55O10P (642.3533)

PA 18:3/12:2;O2

C33H55O10P (642.3533)

PA 20:2/11:2;O

C34H59O9P (642.3896)

PA 22:2/8:3;O2

C33H55O10P (642.3533)

PA 22:4/8:1;O2

C33H55O10P (642.3533)

PA 30:5;O2

C33H55O10P (642.3533)

PA 31:4;O

C34H59O9P (642.3896)

PA 12:0_20:3

C35H63O8P (642.426)

PA 14:0_18:3

C35H63O8P (642.426)

PA 14:1_18:2

C35H63O8P (642.426)

PA 15:1_17:2

C35H63O8P (642.426)

BMP 27:5

C33H55O10P (642.3533)

PG O-10:0/18:5

C34H59O9P (642.3896)

LPI O-22:0

C31H63O11P (642.4108)

PI O-16:0/4:1;O

C29H55O13P (642.338)

PI O-20:1;O

C29H55O13P (642.338)

PI 10:0/10:0

C29H55O13P (642.338)

PI 16:0/4:0

C29H55O13P (642.338)

PI 18:0/2:0

C29H55O13P (642.338)

PI 20:0

C29H55O13P (642.338)

PEth 29:4;O

C34H59O9P (642.3896)

PEth 30:3

C35H63O8P (642.426)

PM 30:4;O

C34H59O9P (642.3896)

PM 31:3

C35H63O8P (642.426)

ST 27:1;O6;GlcA

C33H54O12 (642.3615)

ST 28:0;O5;GlcA

C34H58O11 (642.3979)

ST 27:2;O7;Hex

C33H54O12 (642.3615)

ST 28:1;O6;Hex

C34H58O11 (642.3979)

(1r,2r,6s,7s,8r,10s,12r,14s,16s,17r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-5-oxo-16-(prop-1-en-2-yl)-14-[(1e,3z)-trideca-1,3-dien-1-yl]-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-17-yl acetate

C36H50O10 (642.3404)

2-[1-(9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl)ethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C33H54O12 (642.3615)

(4ar,5s,6r,8ar)-5-{2-[(1r,2r,6s,9r,11s,13r,14s,17s,18s)-11-(furan-3-yl)-9,13-dimethyl-3-oxo-4,10,21-trioxahexacyclo[16.2.1.0²,⁶.0²,¹⁷.0⁶,¹⁴.0⁹,¹³]henicosa-15,19-dien-20-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

C40H50O7 (642.3556)

(1s,3as,5ar,7r,8s,9ar,9br,11ar)-3a,8-dihydroxy-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-[(2r,3r)-2,3,6-trihydroxy-6-methylheptan-2-yl]-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C33H54O12 (642.3615)

1-(2,6-dihydroxy-6-methyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl)-3a,7,8-trihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C33H54O12 (642.3615)

(1s,3as,5ar,7r,8s,9ar,9br,11ar)-1-[(2r,3r)-2,3-dihydroxy-6-methyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-3a,7,8-trihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C33H54O12 (642.3615)

6-{7-[(3-hydroxy-5-methoxy-3-methyl-5-oxopentanoyl)oxy]-3a,6,6,9a,11a-pentamethyl-11-oxo-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h-cyclopenta[a]phenanthren-1-yl}-2-methyl-3-methylideneheptanoic acid

C38H58O8 (642.4131)

(2s,3r,4s)-3-hydroxy-4-[(2s,5r,7s,8r,9s)-9-hydroxy-2-[(2s,2'r,3's,5r,5'r)-5'-[(2s,3s,5r,6r)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-2,3'-dimethyl-[2,2'-bioxolan]-5-yl]-2,8-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl]-2-methylpentanoic acid

C34H58O11 (642.3979)

(1s,3as,5ar,7r,8s,9ar,9br,11ar)-1-[(2r,3r)-2,6-dihydroxy-6-methyl-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-3a,7,8-trihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C33H54O12 (642.3615)

3,4,5-trihydroxyoxan-2-yl (2r,4z)-2-[(1r,3ar,5ar,7r,9as,11ar)-7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-5,6-dimethylhepta-4,6-dienoate

C38H58O8 (642.4131)

1-(2,3-dihydroxy-6-methyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl)-3a,7,8-trihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C33H54O12 (642.3615)

20β-ecdysterone 2-o-β-d-glucopyranoside

C33H54O12 (642.3615)

{"Ingredient_id": "HBIN003389","Ingredient_name": "20\u03b2-ecdysterone 2-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C33H54O12","Ingredient_Smile": "CC12CCC3C(=CC(=O)C4C3(CC(C(C4)O)OC5C(C(C(C(O5)CO)O)O)O)C)C1(CCC2C(C)(C(CCC(C)(C)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6679","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1s,3as,5ar,7r,8s,9ar,9br,11ar)-3a,8-dihydroxy-9a,11a-dimethyl-7-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-[(2r,3r)-2,3,6-trihydroxy-6-methylheptan-2-yl]-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C33H54O12 (642.3615)

(1s,3r,4r,5r,6s,10s,12s,16r,18s,21r)-4,6,12,17,17-pentamethyl-8-(2-methylpropanoyl)-18-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosa-7,13-dien-3-yl acetate

C37H54O9 (642.3768)

4,6,8,10,12,14,15,16,27-nonahydroxy-3-(1-hydroxybutyl)-17,28-dimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one

C33H54O12 (642.3615)

(2s,3r,4s)-3-hydroxy-4-[(2s,5r,8r,9s)-9-hydroxy-2-[(2s,3's)-5'-[(3s,5r,6r)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-2,3'-dimethyl-[2,2'-bioxolan]-5-yl]-2,8-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl]-2-methylpentanoic acid

C34H58O11 (642.3979)

6-(acetyloxy)-n-(1-carbamimidoyl-2-hydroxy-3,4-dihydro-2h-pyridin-3-yl)-1-(2-{[1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-methylpentanoyl)-octahydroindole-2-carboximidic acid

C32H46N6O8 (642.3377)

6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-5-oxo-16-(prop-1-en-2-yl)-14-(trideca-1,3-dien-1-yl)-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-17-yl acetate

C36H50O10 (642.3404)

3,4,5-trihydroxyoxan-2-yl 2-[7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-5,6-dimethylhepta-4,6-dienoate

C38H58O8 (642.4131)

(2r,3ar,6r,7ar)-6-(acetyloxy)-n-(1-carbamimidoyl-2-hydroxy-3,4-dihydro-2h-pyridin-3-yl)-1-[(2r,3s)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-methylpentanoyl]-octahydroindole-2-carboximidic acid

C32H46N6O8 (642.3377)

(6s,9s,12s,15s,20as)-12-[(2s)-butan-2-yl]-1,4,7,10,13-pentahydroxy-15-[(4-hydroxyphenyl)methyl]-9-isopropyl-6-(2-methylpropyl)-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[1,2-a]1,4,7,10,13,16-hexaazacyclooctadecan-16-one

C33H50N6O7 (642.3741)

5,7',9',13'-tetramethyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-15',16',18',19'-tetrol

C33H54O12 (642.3615)

1-[1-(3,4-dimethyl-5-oxo-2h-furan-2-yl)propan-2-yl]-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl 1-methyl 3-hydroxy-3-methylpentanedioate

C38H58O8 (642.4131)

(1s,3as,5ar,7r,8s,9ar,9br,11ar)-1-[(2r,3r,5s)-2,3-dihydroxy-6-methyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-3a,7,8-trihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C33H54O12 (642.3615)

(3s,4s)-4-[(2s,5r,7s,8r,9s)-9-hydroxy-2-[(2s,2'r,3's,5r,5'r)-5'-[(2s,3s,5r,6r)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-2,3'-dimethyl-[2,2'-bioxolan]-5-yl]-2,8-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl]-3-methoxypentanoic acid

C34H58O11 (642.3979)

macrocarpamine

C41H46N4O3 (642.357)

(2r,3r,4s,5s,6r)-2-[(1s)-1-[(1s,3as,3bs,7s,9ar,9bs,11as)-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethoxy]-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C33H54O12 (642.3615)

(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13's,14's,15's,16's,17's,18'r)-5,7',9',13'-tetramethyl-18'-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-14',15',16',17'-tetrol

C33H54O12 (642.3615)

1-(2,3-dihydroxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl)-3a,7,8-trihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C33H54O12 (642.3615)

(1's,2r,2's,4s,4's,5s,7's,8'r,9's,12's,13'r,15'r,16'r,18'r,19'r)-5,7',9',13'-tetramethyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-15',16',18',19'-tetrol

C33H54O12 (642.3615)

{11-ethyl-8,9-dihydroxy-6,16,18-trimethoxy-4-[(2-methylpropanoyl)oxy]-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methyl 2-aminobenzoate

C35H50N2O9 (642.3516)

2-[(4-{[3a-hydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-tetradecahydrocyclopenta[a]phenanthren-7-yl]oxy}-1-hydroxy-4-oxobutylidene)amino]-5-carbamimidamidopentanoic acid

C34H50N4O8 (642.3628)

(1r,5r,6s,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-1,5,6-tris(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C41H54O6 (642.392)

(2s,3e,5r,6r,7r,8r)-7-(acetyloxy)-8-(6-ethyl-3,5-dimethyl-4-oxopyran-2-yl)-2-{6-[(2s,3s)-3-hydroxypentan-2-yl]-3,5-dimethyl-4-oxopyran-2-yl}-4,6-dimethylnon-3-en-5-yl propanoate

C37H54O9 (642.3768)

(2r,3r,4r,5r,6e,8s)-5-(acetyloxy)-2-(6-ethyl-3,5-dimethyl-4-oxopyran-2-yl)-8-{6-[(2s,3s)-3-hydroxypentan-2-yl]-3,5-dimethyl-4-oxopyran-2-yl}-4,6-dimethylnon-6-en-3-yl propanoate

C37H54O9 (642.3768)

5-{[(3r,3ar,5ar,8r,9ar,9bs)-3-[(2r,6s)-6-[1-(5,5-dimethyl-4-oxofuran-2-yl)ethenyl]-2-hydroxy-5,6-dihydro-2h-pyran-3-yl]-3a,6,6,9a-tetramethyl-7-oxo-octahydro-1h-cyclopenta[a]naphthalen-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C36H50O10 (642.3404)

(1r,2r,6s,7s,8r,10s,11s,12r,14s,16s,17r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-5-oxo-16-(prop-1-en-2-yl)-14-[(1e,3z)-trideca-1,3-dien-1-yl]-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-17-yl acetate

C36H50O10 (642.3404)

5-{2-[11-(furan-3-yl)-9,13-dimethyl-3-oxo-4,10,21-trioxahexacyclo[16.2.1.0²,⁶.0²,¹⁷.0⁶,¹⁴.0⁹,¹³]henicosa-15,19-dien-20-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

C40H50O7 (642.3556)

methyl (13e)-17-(2-{3,20-dimethyl-15-oxa-3,20-diazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8,16-pentaen-17-yl}ethenyl)-13-ethylidene-1,11-diazapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6-triene-18-carboxylate

C41H46N4O3 (642.357)

5,7',9',13'-tetramethyl-18'-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-14',15',16',17'-tetrol

C33H54O12 (642.3615)

(2s,6r)-6-[(1r,3as,5ar,7r,9as,11ar)-7-{[(3s)-3-hydroxy-5-methoxy-3-methyl-5-oxopentanoyl]oxy}-3a,6,6,9a,11a-pentamethyl-11-oxo-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C38H58O8 (642.4131)

(3r,4r,6r,8s,10r,12r,14r,16s,17z,19e,21e,23e,25e,27s,28s)-4,6,8,10,12,14,15,16,27-nonahydroxy-3-[(1s)-1-hydroxybutyl]-17,28-dimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one

C33H54O12 (642.3615)

(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13's,14's,15's,16's,17's,18'r)-5,7',9',13'-tetramethyl-18'-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-14',15',16',17'-tetrol

C33H54O12 (642.3615)

(1r,2r,4e,24r,27r)-18-butyl-1,2,9,14,19,22,27-heptahydroxy-4,6,15-trimethyl-10-methylidene-12,17,28-trioxatricyclo[22.3.1.0¹¹,¹³]octacos-4-ene-7,16-dione

C33H54O12 (642.3615)

(1r,3s,6r,7r,8s,11r,12s,15s,16s,19r,20s,21r,23s)-1,19,23-trihydroxy-8-(4-hydroxybenzoyloxy)-20-(hydroxymethyl)-3,7,11,16,20-pentamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricosane-7-carboxylic acid

C37H54O9 (642.3768)

1,4,7,10,13-pentahydroxy-15-[(4-hydroxyphenyl)methyl]-9-isopropyl-6-(2-methylpropyl)-12-(sec-butyl)-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[1,2-a]1,4,7,10,13,16-hexaazacyclooctadecan-16-one

C33H50N6O7 (642.3741)

(1r,3r,5r,6as,7s,8s,9r,10r,10as)-1,3,10-tris(acetyloxy)-5-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl (2e,4e)-deca-2,4-dienoate

C36H50O10 (642.3404)

(1r,3as,5ar,7r,9as,11s,11ar)-1-[(2r)-1-[(2s)-3,4-dimethyl-5-oxo-2h-furan-2-yl]propan-2-yl]-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl 1-methyl (3s)-3-hydroxy-3-methylpentanedioate

C38H58O8 (642.4131)

4-(9-hydroxy-2-{5'-[6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-2,3'-dimethyl-[2,2'-bioxolan]-5-yl}-2,8-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl)-3-methoxypentanoic acid

C34H58O11 (642.3979)

1,19,23-trihydroxy-8-(4-hydroxybenzoyloxy)-20-(hydroxymethyl)-3,7,11,16,20-pentamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricosane-7-carboxylic acid

C37H54O9 (642.3768)

(3s,4s)-4-[(2s,7s,8r,9s)-9-hydroxy-2-[(2s,2'r,3's,5r,5'r)-5'-[(2s,3s,5r,6r)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-2,3'-dimethyl-[2,2'-bioxolan]-5-yl]-2,8-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl]-3-methoxypentanoic acid

C34H58O11 (642.3979)

methyl (1r,12r,19s)-12-ethyl-4-[(15s,19r)-15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18),13-pentaen-17-yl]-5-methoxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2(7),3,5,9,13-pentaene-10-carboxylate

C41H46N4O3 (642.357)

1,3,10-tris(acetyloxy)-5-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl deca-2,4-dienoate

C36H50O10 (642.3404)

[(1r,3s,3ar,5as,5bs,6s,7ar,9s,11as,13ar,13br)-1,6,9-tris(acetyloxy)-3-isopropyl-5a,8,8,11a,13a-pentamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-3a-yl]methyl acetate

C38H58O8 (642.4131)

methyl (1s,12r,19r)-12-ethyl-4-[(15r,17s,19r)-15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18),13-pentaen-17-yl]-5-methoxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2(7),3,5,9,13-pentaene-10-carboxylate

C41H46N4O3 (642.357)

1-[(2r)-2,6-dihydroxy-6-methyl-3-{[(3s,4r,5r,6r)-4,5,6-trihydroxy-3-methoxyoxepan-3-yl]oxy}heptan-2-yl]-3a,7,8-trihydroxy-11a-methyl-1h,2h,3h,5ah,6h,7h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C33H54O12 (642.3615)

[(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-8,9-dihydroxy-6,16,18-trimethoxy-4-[(2-methylpropanoyl)oxy]-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

C35H50N2O9 (642.3516)

(1s,3as,5as,7r,8r,9ar,9br,11ar)-1-[(2r,3r)-2,6-dihydroxy-6-methyl-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-3a,7,8-trihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C33H54O12 (642.3615)

methyl (1r,2r,3r,7s,9r,11s,13s,14r)-7-(hexadecanoyloxy)-5-oxo-2,9-bis(prop-1-en-2-yl)-4,12,15,16-tetraoxapentacyclo[9.4.1.1³,⁶.0¹,¹⁴.0¹¹,¹³]heptadec-6(17)-ene-13-carboxylate

C37H54O9 (642.3768)

3a,8-dihydroxy-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-(2,3,6-trihydroxy-6-methylheptan-2-yl)-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C33H54O12 (642.3615)

(2s)-2-[(4-{[(1r,3as,3br,5ar,7s,9as,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-tetradecahydrocyclopenta[a]phenanthren-7-yl]oxy}-1-hydroxy-4-oxobutylidene)amino]-5-carbamimidamidopentanoic acid

C34H50N4O8 (642.3628)

4,6,12,17,17-pentamethyl-8-(2-methylpropanoyl)-18-[(3,4,5-trihydroxyoxan-2-yl)oxy]-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosa-7,13-dien-3-yl acetate

C37H54O9 (642.3768)

(1r,2r,6s,7s,8r,10s,11s,12r,14s,16s,17r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-5-oxo-16-(prop-1-en-2-yl)-14-[(1e,3e)-trideca-1,3-dien-1-yl]-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-17-yl acetate

C36H50O10 (642.3404)

2-(1-{7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethoxy)-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C33H54O12 (642.3615)

(1r,2r,6s,7s,8r,10s,11s,12r,14s,16s,17r,18s)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-5-oxo-16-(prop-1-en-2-yl)-14-[(1e,3e)-trideca-1,3-dien-1-yl]-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-17-yl acetate

C36H50O10 (642.3404)

(2r,3r,4r,5s)-3,4,5-trihydroxyoxan-2-yl (2r,4z)-2-[(1r,3ar,5ar,7r,9as,11ar)-7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-5,6-dimethylhepta-4,6-dienoate

C38H58O8 (642.4131)

(2r,3r,4s,5s,6r)-2-[(1s)-1-[(1s,3as,3bs,7s,9ar,9bs,11as)-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C33H54O12 (642.3615)

(2r,6s,7s,8r,10s,11s,12r,14r,16s,17r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-5-oxo-16-(prop-1-en-2-yl)-14-[(1e,3e)-trideca-1,3-dien-1-yl]-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-17-yl acetate

C36H50O10 (642.3404)